Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • Research Grant, 2022
    Cognitive Assessment of Non-Human Primate Models of Parkinson's Disease

    Study Rationale: Cognitive impairments cause significant disability for people with Parkinson’s disease (PD). Problems such as reduced attention or difficulty following plans can occur very early in...

  • Translational Pipeline Program, 2022
    Investigating GPR55 as a Novel Neuroprotective Target in Preclinical Models of Parkinson’s Disease

    Study Rationale: Cannabinoids — substances derived from the cannabis plant — have demonstrated neuroprotective properties useful for the treatment of neurodegenerative disorders. Although these...

  • Novel PET Tracer Development Program, 2022
    Screening for PET Tracers that will Bind to the P2Y12 Receptor and Allow Monitoring of Microglia Activation During Neuroinflammation

    Study Rationale: One of the hallmarks of Parkinson’s disease (PD) is neuroinflammation. During this dynamic process, the brain’s immune cells, called microglia, become activated and can either prolong...

  • Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program, 2022
    Glucocerebrosidase Activation as a Therapeutic Strategy for Parkinson’s Disease

    Study Rationale: Mutations in GBA1, the gene that encodes glucocerebrosidase (GCase), diminish GCase activity in an estimated 7 to 10% of people with Parkinson’s disease (PD). In addition, reduced...

  • Research Grant, 2022
    Parkinson’s Disease Treatment Evaluation and Access Strategy: Phase 1

    Study Rationale: Core funding programs at The Michael J. Fox Foundation (MJFF) have historically focused on research to understand, measure, and treat Parkinson’s disease (PD). MJFF is now seeking to...

  • Biomarkers to Support Therapeutic Trials Program, 2022
    Identifying Biomarkers for a Mitochondrial Subtype of Parkinson’s Disease

    Study Rationale: Increasing evidence suggests that the disorder we refer to as Parkinson’s disease (PD) might represent several diseases, each driven by different biological mechanisms. The...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.